[{"Assets_0_Q2_USD":"4143459000.0","CIK":"12208","Country":"United States","EarningsPerShareBasic_1_Q2_USD":"0.17","EarningsPerShareBasic_2_Q2_USD":"0.59","EarningsPerShareDiluted_1_Q2_USD":"0.17","EarningsPerShareDiluted_2_Q2_USD":"0.58","Industry":"Biotechnology: Laboratory Analytical Instruments","Market":"NYSE","Market Cap":"16656203893.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":"6200000.0","NetIncomeLossConverted_1_Q2_USD":"5035000.0","NetIncomeLossConverted_2_Q2_USD":"17448000.0","OfficialName":"Bio-Rad Laboratories Inc. Class A Common Stock","RevenuesConverted_1_Q2_USD":"504666000.0","RevenuesConverted_2_Q2_USD":"1004717000.0","SP500":"SP500","Sector":"Capital Goods","StockholdersEquity_0_Q2_USD":"2810997000.0","Ticker":"BIO","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":"30006000.0","WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":"29962000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":"29613000.0","WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":"29597000.0","filed":"20170807","footnote":null,"form":"10-Q","fp":"Q2","fy":"2017.0","name":"BIO RAD LABORATORIES INC","period":"20170630","qtrs":"0","uom":"USD"}]